Amalgam

Amalgam Rx

United States · Founded 2016

Employees
11–50
Founded
2016
Business Model
B2B
Last Round
Series BJan 2023
Rounds
1

About

Amalgam Rx creates and distributes regulated digital products, including digital medicine, patient identification, clinical decision support, and clinical trial recruiting, on a modular platform integrated into EHR workflows. The company partners with life sciences companies, health plans, and providers to build Software as a Medical Device solutions and Medical-Grade AI applications. Amalgam's algorithms and applications support nearly 10 million patients across four continents and have helped providers make over 50 million decisions. Its leadership has nearly two decades of experience developing, clearing, and deploying EHR solutions and digital therapeutics.

Summary

Amalgam is an Artificial Intelligence company based in United States, founded in 2016. Its most recent funding was a Series B round in Jan 2023. Investors include Catalio Capital Management and CVS Health Ventures.

Tech & App Stack

7 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Credit LineCredit InvestmentAug 2025
$20.0M

Sign up to see all 2 rounds

Series B through Credit Line — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Amalgam on Indexed.vc
<a href="https://indexed.vc/companies/amalgam"><img src="https://indexed.vc/api/badge/company/amalgam" alt="Amalgam on Indexed.vc" width="260" height="76" /></a>